Reiter Y - Search Results

1

Recombinant single-chain and disulfide-stabilized Fv immunotoxins for cancer therapy.

Niv R, Segal D, Reiter Y. Niv R, et al. Among authors: reiter y. Methods Mol Biol. 2003;207:255-68. doi: 10.1385/1-59259-334-8:255. Methods Mol Biol. 2003. PMID: 12412479 No abstract available.

2

Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure.

Reiter Y, Kurucz I, Brinkmann U, Jung SH, Lee B, Segal DM, Pastan I. Reiter Y, et al. Immunity. 1995 Mar;2(3):281-7. doi: 10.1016/1074-7613(95)90052-7. Immunity. 1995. PMID: 7697545 Free article.

3

Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog.

Webber KO, Reiter Y, Brinkmann U, Kreitman R, Pastan I. Webber KO, et al. Among authors: reiter y. Mol Immunol. 1995 Mar;32(4):249-58. doi: 10.1016/0161-5890(94)00150-y. Mol Immunol. 1995. PMID: 7723770

4

Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.

Reiter Y, Brinkmann U, Lee B, Pastan I. Reiter Y, et al. Nat Biotechnol. 1996 Oct;14(10):1239-45. doi: 10.1038/nbt1096-1239. Nat Biotechnol. 1996. PMID: 9631086 Review.

5

Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.

Reiter Y, Pastan I. Reiter Y, et al. Clin Cancer Res. 1996 Feb;2(2):245-52. Clin Cancer Res. 1996. PMID: 9816166 Review.

6

Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis.

Reiter Y, Pastan I. Reiter Y, et al. Trends Biotechnol. 1998 Dec;16(12):513-20. doi: 10.1016/s0167-7799(98)01226-8. Trends Biotechnol. 1998. PMID: 9881483 Review.

7

An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface.

Reiter Y, Schuck P, Boyd LF, Plaksin D. Reiter Y, et al. J Mol Biol. 1999 Jul 16;290(3):685-98. doi: 10.1006/jmbi.1999.2923. J Mol Biol. 1999. PMID: 10395823

8

Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens.

Denkberg G, Cohen CJ, Segal D, Kirkin AF, Reiter Y. Denkberg G, et al. Among authors: reiter y. Eur J Immunol. 2000 Dec;30(12):3522-32. doi: 10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO;2-D. Eur J Immunol. 2000. PMID: 11093172 Free article.

9

Recombinant immunotoxins in targeted cancer cell therapy.

Reiter Y. Reiter Y. Adv Cancer Res. 2001;81:93-124. doi: 10.1016/s0065-230x(01)81003-4. Adv Cancer Res. 2001. PMID: 11430597 Review.

10

Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxins.

Niv R, Cohen CJ, Denkberg G, Segal D, Reiter Y. Niv R, et al. Among authors: reiter y. Curr Pharm Biotechnol. 2001 Mar;2(1):19-46. doi: 10.2174/1389201013378824. Curr Pharm Biotechnol. 2001. PMID: 11482347 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters